Integrating evidence for managing asthma in patients who smoke

Allergy, Asthma and Immunology Research

Volumn 6, Issue 2, 2014, Pages 114-120

  Price, David ^a,b   Bjermer, Leif ^b,c   Popov, Todor A ^b,d   Chisholm, Alison ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Respiratory Effectiveness Group   (United Kingdom)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

asthma; extra fine particle; inhaled glucocorticosteroids (ICS); leukotriene receptor antagonists (LTRAs); small airways; Smoking

Indexed keywords

EID: 84894442822     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2014.6.2.114     Document Type: Review

References (38)

1. Herland K, Akselsen JP, Skjønsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 2005;99:11-9.
2. Costa DJ, Amouyal M, Lambert P, Ryan D, Schünemann HJ, Daures JP, Bousquet J, Bousquet PJ; Languedoc-Roussillon Teaching General Practitioners Group. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol 2011;127: 920-926. e1.
3. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18:300-5.
4. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsäter A, Bjermer L. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008;102:1681-93.
5. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, McSharry CP, Thomson NC. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006;174:127-33.
6. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30.
7. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003;111:3-22.
8. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139:359-70.
9. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000;20:6891-903.
10. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-7.
11. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216-20.
12. Choi JS, Jang AS, Park JS, Park SW, Paik SH, Park JS, Uh ST, Kim YH, Park CS. Role of neutrophils in persistent airway obstruction due to refractory asthma. Respirology 2012;17:322-9.
13. Gaki E, Papatheodorou G, Ischaki E, Grammenou V, Papa I, Loukides S. Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit. Respir Med 2007;101:826-32.
14. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:24-31.
15. Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011;20:23-33.
16. Saareks V, Riutta A, Alanko J, Ylitalo P, Parviainen M, Mucha I, Sievi E, Vapaatalo H. Clinical pharmacology of eicosanoids, nicotine induced changes in man. J Physiol Pharmacol 2000;51:631-42.
17. Dahlén SE. Pharmacological characterization of leukotriene receptors. Am J Respir Crit Care Med 2000;161:S41-5.
18. Wennergren G. Inflammatory mediators in blood and urine. Paediatr Respir Rev 2000;1:259-65.
19. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-54.
20. Wiggs BR, Bosken C, Paré PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.
21. Paré PD, Roberts CR, Bai TR, Wiggs BJ. The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis 1997; 52:589-96.
22. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-38.
23. Global Initiative for Asthma (US). GINA Report, Global Strategy for Asthma Management and Prevention [Internet]. [place unknown]: Global Initiative for Asthma; 2012 [cited 2013 Aug 29]. Available from: www.ginasthma.org.
24. Chang YS. New Treatment for smoking asthmatics. KAPARD-KAAACI & West Pacific Allergy Symposium Joint International Congress; 2013 May 10-11; Grand Hilton Seoul Hotel. Seoul: Korean Academy of Pediatric Allergy and Respiratory Disease; 2013.
25. Broekema M, ten Hacken NH, Volbeda F, Lodewijk ME, Hylkema MN, Postma DS, Timens W. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180:1170-8.
26. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005;60:282-7.
27. Price D, Popov TA, Bjermer L, Lu S, Petrovic R, Vandormael K, Mehta A, Strus JD, Polos PG, Philip G. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-71.
28. Leach C, Colice GL, Luskin A. Particle size of inhaled corticosteroids: does it matter? J Allergy Clin Immunol 2009;124:S88-93.
29. Micheletto C, Guerriero M, Tognella S, Dal Negro RW. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. Respir Med 2005; 99:850-5.
30. Häussermann S, Acerbi D, Brand P, Herpich C, Poli G, Sommerer K, Meyer T. Lung deposition of formoterol HFA (Atimos/Forair) in healthy volunteers, asthmatic and COPD patients. J Aerosol Med 2007;20:331-41.
31. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler. J Aerosol Med 2005;18:379-85.
32. Clinical Practice Research Datalink(GB). Clinical Practice Research Datalink [Internet]. London: Clinical Practice Research Datalink; 2013 [cited 2013 Aug 20]. Available from: http://www.cprd.com/home/.
33. Optimum Patient Care Research Database (GB). Optimum Patient Care Research Database [Internet]. Cambridge: Optimum Patient Care Research Database; 2013 [cited 2013 Aug 20]. Available from: http://www.optimumpatientcare.org/Html_Docs/OPCRD.html.
34. Research in Real Life Limited (GB). Research in Real Life [Internet]. Cambridge: Research in Real Life Limited; 2013 [cited 2013 Dec 16] Available from: http://rirl.org/.
35. Rider CF, King EM, Holden NS, Giembycz MA, Newton R. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists. J Pharmacol Exp Ther 2011;338:860-9.
36. Clearie KL, McKinlay L, Williamson PA, Lipworth BJ. Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke. Chest 2012;141:330-8.
37. Brusselle G, Peché R, Van den Brande P, Verhulst A, Hollanders W, Bruhwyler J. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status. Respir Med 2012;106:811-9.
38. Martin R, Price D, McIvor A, Wong G, Krishnan J, Campbell JD, Bjermer L, Miravitlles M, Chisholm A, Burden A. Real-life asthma impairment: SABA use depends on smoking phenotype. European Respiratory Society Annual Congress 2013; 2013 Sep 7-11; Barcelona. Lausanne: European Respiratory; 2013.